<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Int J Epidemiol</journal-id>
    <journal-id journal-id-type="iso-abbrev">Int J Epidemiol</journal-id>
    <journal-id journal-id-type="publisher-id">ije</journal-id>
    <journal-title-group>
      <journal-title>International Journal of Epidemiology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0300-5771</issn>
    <issn pub-type="epub">1464-3685</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6659377</article-id>
    <article-id pub-id-type="doi">10.1093/ije/dyy195</article-id>
    <article-id pub-id-type="publisher-id">dyy195</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software Application Profile</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Software application profile: mrrobust—a tool for performing two-sample summary Mendelian randomization analyses</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8169-5531</contrib-id>
        <name>
          <surname>Spiller</surname>
          <given-names>Wes</given-names>
        </name>
        <xref ref-type="aff" rid="dyy195-aff1">1</xref>
        <xref ref-type="corresp" rid="dyy195-cor1"/>
        <!--<email>wes.spiller@bristol.ac.uk</email>-->
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2460-0508</contrib-id>
        <name>
          <surname>Davies</surname>
          <given-names>Neil M</given-names>
        </name>
        <xref ref-type="aff" rid="dyy195-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4655-4511</contrib-id>
        <name>
          <surname>Palmer</surname>
          <given-names>Tom M</given-names>
        </name>
        <xref ref-type="aff" rid="dyy195-aff2">2</xref>
      </contrib>
    </contrib-group>
    <aff id="dyy195-aff1"><label>1</label>Population Health Science Institute, University of Bristol, Bristol, UK</aff>
    <aff id="dyy195-aff2"><label>2</label>Department of Mathematics and Statistics, Lancaster University, Lancaster, UK</aff>
    <author-notes>
      <corresp id="dyy195-cor1">Corresponding author. MRC Integrative Epidemiology Unit, Population Health Institute, University of Bristol, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK. E-mail: <email>wes.spiller@bristol.ac.uk</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <month>6</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2018-09-12">
      <day>12</day>
      <month>9</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>12</day>
      <month>9</month>
      <year>2018</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>48</volume>
    <issue>3</issue>
    <issue-title>Special theme: Mendelian randomization</issue-title>
    <fpage>684</fpage>
    <lpage>690</lpage>
    <history>
      <date date-type="accepted">
        <day>22</day>
        <month>8</month>
        <year>2018</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2018. Published by Oxford University Press on behalf of the International Epidemiological Association.</copyright-statement>
      <copyright-year>2018</copyright-year>
      <license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="dyy195.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>In recent years, Mendelian randomization analysis using summary data from genome-wide association studies has become a popular approach for investigating causal relationships in epidemiology. The mrrobust Stata package implements several of the recently developed methods.</p>
      </sec>
      <sec id="s2">
        <title>Implementation</title>
        <p>mrrobust is freely available as a Stata package.</p>
      </sec>
      <sec id="s3">
        <title>General features</title>
        <p>The package includes inverse variance weighted estimation, as well as a range of median, modal and MR-Egger estimation methods. Using mrrobust, plots can be constructed visualizing each estimate either individually or simultaneously. The package also provides statistics such as<inline-formula id="IE1"><mml:math id="IM1"><mml:mi mathvariant="normal"> </mml:mi><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula>, which are useful in assessing attenuation bias in causal estimates.</p>
      </sec>
      <sec id="s4">
        <title>Availability</title>
        <p>The software is freely available from GitHub [<ext-link ext-link-type="uri" xlink:href="https://raw.github.com/remlapmot/mrrobust/master/">https://raw.github.com/remlapmot/mrrobust/master/</ext-link>].</p>
      </sec>
    </abstract>
    <kwd-group kwd-group-type="author">
      <kwd>Summary MR</kwd>
      <kwd>MR-Egger</kwd>
      <kwd>IVW</kwd>
      <kwd>weighted median</kwd>
      <kwd>Mendelian randomization</kwd>
      <kwd>Stata</kwd>
    </kwd-group>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Medical Research Council</named-content>
          <named-content content-type="funder-identifier">10.13039/501100000265</named-content>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">MRC</named-content>
          <named-content content-type="funder-identifier">10.13039/501100000265</named-content>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">University of Bristol</named-content>
          <named-content content-type="funder-identifier">10.13039/501100000883</named-content>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">MRC Integrative Epidemiology Unit</named-content>
        </funding-source>
        <award-id>MC UU 12013/1</award-id>
        <award-id>MC UU 12013/9</award-id>
        <award-id>MC UU 00011/1</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Wellcome Trust</named-content>
          <named-content content-type="funder-identifier">10.13039/100004440</named-content>
        </funding-source>
        <award-id>108902/B/15/Z</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <p>
    <boxed-text id="dyy195-BOX1" position="float" orientation="portrait">
      <sec>
        <title>Key Messages</title>
        <list list-type="bullet">
          <list-item>
            <p>The mrrobust software package facilitates two-sample summary MR analyses using summary data from genome-wide association studies.</p>
          </list-item>
          <list-item>
            <p>The package allows for implementation of a range of summary MR estimators using Stata, improving the extent to which results are reproducible.</p>
          </list-item>
          <list-item>
            <p>Conclusions from the supported analyses can be robust to sources of confounding bias and pleiotropy, though findings should be considered with respect to the underlying assumptions of each estimator.</p>
          </list-item>
        </list>
      </sec>
    </boxed-text>
  </p>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>Mendelian randomization<xref rid="dyy195-B1" ref-type="bibr"><sup>1</sup></xref> has developed into a popular approach to examining causal relationships in epidemiology.<xref rid="dyy195-B2" ref-type="bibr"><sup>2</sup></xref><sup>,</sup><xref rid="dyy195-B3" ref-type="bibr"><sup>3</sup></xref> By employing genetic variants as instrumental variables (IVs) it is possible to limit bias from confounding, provided variants satisfy the assumptions of IV analysis.<xref rid="dyy195-B1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="dyy195-B4" ref-type="bibr"><sup>4</sup></xref> For a genetic variant to serve as a suitable instrument, three assumptions must hold: (i) it must be associated with the exposure of interest; (ii) there must be no confounders of the instrument and outcome; and (iii) the instrument must not affect the outcome except via the exposure of interest.<xref rid="dyy195-B5" ref-type="bibr"><sup>5</sup></xref></p>
    <p>Candidate variants are usually identified through large genome-wide association studies (GWASs).<xref rid="dyy195-B6" ref-type="bibr"><sup>6</sup></xref> However, IV analyses using single variants rarely have sufficient power to test hypotheses of interest.<xref rid="dyy195-B6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="dyy195-B7" ref-type="bibr"><sup>7</sup></xref> One approach to increase the statistical power of Mendelian randomization studies is to use multiple genetic variants as instruments within a two-sample summary framework.<xref rid="dyy195-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyy195-B9" ref-type="bibr"><sup>9</sup></xref> Two-sample Mendelian randomization estimates the effect of the exposure using instrument-exposure and instrument-outcome associations from different samples, often through methods originally developed for meta-analysis.<xref rid="dyy195-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyy195-B9" ref-type="bibr"><sup>9</sup></xref> This is particularly useful as MR estimators, such as MR Egger and median based regression, are robust to certain forms of violation of the third instrumental variable assumption.<xref rid="dyy195-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyy195-B10" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="dyy195-B11" ref-type="bibr"><sup>11</sup></xref> Violations of this assumption can occur through directional pleiotropy, where a genetic variant affects the study outcome through pathways that are not mediated via the exposure. Such developments have contributed to the increasing popularity of two-sample summary MR.<xref rid="dyy195-B5" ref-type="bibr"><sup>5</sup></xref></p>
    <p>This paper introduces the mrrobust Stata package as a tool to help researchers implement two-sample MR analyses, and can be viewed as the Stata counterpart to toolkits such as the MR-Base web application, and the MendelianRandomization and TwoSampleMR R packages.<xref rid="dyy195-B12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="dyy195-B13" ref-type="bibr"><sup>13</sup></xref> Whereas it is possible to conduct individual-level IV analyses in Stata using modules such as IVREG2,<xref rid="dyy195-B14" ref-type="bibr"><sup>14</sup></xref> two-sample summary MR has previously required bespoke code to implement. The mrrobust package addresses this limitation, providing a suite of popular two-sample MR methods and sensitivity analyses. Before continuing, we briefly outline the three primary estimation methods included in the mrrobust package, using the notation of Bowden <italic>et al.</italic><xref rid="dyy195-B10" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="dyy195-B15" ref-type="bibr"><sup>15</sup></xref></p>
  </sec>
  <sec sec-type="methods">
    <title>Methods</title>
    <sec>
      <title>Inverse variance weighting (IVW)</title>
      <p>To perform IVW, a weighted average<inline-formula id="IE2"><mml:math id="IM2"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>V</mml:mi><mml:mi>W</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> is calculated using the set of ratio estimates <inline-formula id="IE3"><mml:math id="IM3"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>J</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> for each individual variant<inline-formula id="IE4"><mml:math id="IM4"><mml:mi mathvariant="normal"> </mml:mi><mml:mi>J</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>.</mml:mo></mml:math></inline-formula><xref rid="dyy195-B9" ref-type="bibr"><sup>9</sup></xref> Ratio estimates are obtained for each variant by dividing the instrument-outcome association by the corresponding instrument-exposure association. Such association estimates are obtained by fitting simple linear regression models of the outcome and exposure upon the genetic variant, primarily by conducting a GWAS. Let<inline-formula id="IE5"><mml:math id="IM5"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula id="IE6"><mml:math id="IM6"><mml:msubsup><mml:mrow><mml:mo>σ</mml:mo></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> denote the instrument-outcome association and variance, respectively, for the<inline-formula id="IE7"><mml:math id="IM7"><mml:mi mathvariant="normal"> </mml:mi><mml:msup><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> variant. The IVW estimate is then defined as:
<disp-formula id="E1"><mml:math id="M1"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>V</mml:mi><mml:mi>W</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>J</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>J</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>σ</mml:mo></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:math></disp-formula></p>
      <p>This corresponds to the estimate one would obtain from a weighted linear regression of the set of instrument-outcome associations upon the set of instrument-exposure associations, constraining the intercept at the origin.<xref rid="dyy195-B9" ref-type="bibr"><sup>9</sup></xref> One drawback of the IVW approach is that causal effect estimates can be biased in cases where one or more variants exhibit directional pleiotropy.<xref rid="dyy195-B9" ref-type="bibr"><sup>9</sup></xref></p>
    </sec>
    <sec>
      <title>MR-Egger regression</title>
      <p>MR-Egger regression is valid under weaker assumptions than IVW, as it can provide unbiased causal effect estimates even if the variants have pleiotropic effects. In this case, the set of instrument-outcome associations is regressed upon the set of instrument-exposure associations, weighting the regression using precision of the instrument-outcome associations, as in the IVW case.<xref rid="dyy195-B8" ref-type="bibr"><sup>8</sup></xref> However, MR-Egger does not constrain the intercept at the origin, and the intercept represents an estimate of the average directional pleiotropic effect across the set of variants. The slope of the model provides an unbiased estimate of the causal effect.<xref rid="dyy195-B8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="dyy195-B10" ref-type="bibr"><sup>10</sup></xref> If there is little evidence of systematic differences between the IVW and MR-Egger, then the IVW should be preferred. The IVW is more efficient, but potentially less robust, and in such cases the IVW estimate is often the most appropriate estimate to adopt due to the greater precision of IVW estimates in comparison with other approaches.<xref rid="dyy195-B10" ref-type="bibr"><sup>10</sup></xref> If there are differences between the IVW and MR-Egger estimates, this may be due to pleiotropy or to heterogeneous treatment effects.</p>
      <p>The utility of MR Egger regression hinges upon two core assumptions. First, the INstrument Strength Independent of Direct Effect (InSIDE) assumption requires the effects of single nucleotide polymorphisms (SNPs) on the exposure and their pleiotropic effects on the outcome to be independent. If the InSIDE assumption holds, estimates for variants with stronger instrument-exposure associations<inline-formula id="IE8"><mml:math id="IM8"><mml:mi mathvariant="normal"> </mml:mi><mml:mo>(</mml:mo><mml:mrow><mml:mover accent="true"><mml:mrow><mml:msub><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mo>)</mml:mo></mml:math></inline-formula> will be closer to the true causal effect parameter than variants with weaker associations.<xref rid="dyy195-B8" ref-type="bibr"><sup>8</sup></xref> Second, the NO Measurement Error (NOME) assumption requires no measurement error to be present in the instrument-exposure associations, and therefore that the variance of the instrument-exposure association<inline-formula id="IE9"><mml:math id="IM9"><mml:mi mathvariant="normal"> </mml:mi><mml:msubsup><mml:mrow><mml:mo>σ</mml:mo></mml:mrow><mml:mrow><mml:mi>X</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula>. In cases where NOME is strictly satisfied, estimates<inline-formula id="IE10"><mml:math id="IM10"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> will be equal to<inline-formula id="IE11"><mml:math id="IM11"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mo>γ</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and the variance of the ratio estimate for each variant<inline-formula id="IE12"><mml:math id="IM12"><mml:mi mathvariant="normal"> </mml:mi><mml:mi>j</mml:mi></mml:math></inline-formula> is <inline-formula id="IE13"><mml:math id="IM13"><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mo>σ</mml:mo></mml:mrow><mml:mrow><mml:mi>Y</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>γ</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:math></inline-formula>. We further note that the NOME assumption applies to other two-sample MR approaches and is not therefore a unique feature of the MR Egger approach.</p>
      <p>In cases where the NOME assumption is violated, individual variants will suffer from weak instrument bias, leading to attenuation of MR Egger estimates towards the null. This can occur if the SNPs were not genome-wide significant (<inline-formula id="IE14"><mml:math id="IM14"><mml:mi>p</mml:mi><mml:mo>=</mml:mo><mml:mn>5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula>) or were selected from small GWAS. One novel approach to assessing the strength of the NOME assumption is to evaluate the<inline-formula id="IE15"><mml:math id="IM15"><mml:mi mathvariant="normal"> </mml:mi><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> statistic, interpreted as the relative degree of attenuation bias in the MR Egger regression in the interval (0, 1).<xref rid="dyy195-B10" ref-type="bibr"><sup>10</sup></xref> Thus, for example, an <inline-formula id="IE16"><mml:math id="IM16"><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> value of 0.7 represents an estimated relative bias of 30% towards the null. Further details regarding calculation of the <inline-formula id="IE17"><mml:math id="IM17"><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> statistic are presented in the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>, available at <italic>IJE</italic> online.</p>
    </sec>
    <sec>
      <title>Weighted median</title>
      <p>The weighted median approach is an adaptation of the simple median estimator for two-sample summary MR.<xref rid="dyy195-B15" ref-type="bibr"><sup>15</sup></xref> For a total number of variants<inline-formula id="IE18"><mml:math id="IM18"><mml:mi mathvariant="normal"> </mml:mi><mml:mi>J</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:math></inline-formula>, the simple median approach selects the middle ratio estimate<inline-formula id="IE19"><mml:math id="IM19"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:math></inline-formula>, from ordered ratio estimates<inline-formula id="IE20"><mml:math id="IM20"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:math></inline-formula><xref rid="dyy195-B15" ref-type="bibr"><sup>15</sup></xref> In cases where the total number of variants is even, the median is interpolated as<inline-formula id="IE21"><mml:math id="IM21"><mml:mi mathvariant="normal"> </mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math></inline-formula>. As the simple median approach is inefficient, particularly in cases with variable precision in the set of ratio estimates, it is preferable to incorporate weights in a fashion similar to the IVW and MR Egger approaches. Let<inline-formula id="IE22"><mml:math id="IM22"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo stretchy="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></inline-formula> be the sum of weights for the set of variants<inline-formula id="IE23"><mml:math id="IM23"><mml:mi mathvariant="normal"> </mml:mi><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant="normal"> </mml:mi><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mi>j</mml:mi></mml:math></inline-formula>, standardized so the sum of weights<inline-formula id="IE24"><mml:math id="IM24"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>J</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>=1. The weighted median estimator is the median of a distribution having estimate <inline-formula id="IE25"><mml:math id="IM25"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> as its<inline-formula id="IE26"><mml:math id="IM26"><mml:mi mathvariant="normal"> </mml:mi><mml:msub><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mi>h</mml:mi></mml:mrow></mml:msup></mml:math></inline-formula> percentile.<xref rid="dyy195-B15" ref-type="bibr"><sup>15</sup></xref> For the range of percentile values, we perform a linear extrapolation between neighbouring ratio estimates.</p>
      <p>An important assumption of the median summary MR approaches is that more than 50% of the genetic variants do not exhibit directional pleiotropy. In the simple median case, this threshold refers to the number of variants, whereas in the weighted median case, the 50% threshold is with respect to the weights of the non-pleiotropic variants.<xref rid="dyy195-B15" ref-type="bibr"><sup>15</sup></xref></p>
    </sec>
    <sec>
      <title>Additional estimators</title>
      <p>As two-sample MR represents a developing area of genetic epidemiology, novel approaches to causal effect estimation are incorporated into the mrrobust package through frequent updates. One such method is the mode-based estimator put forward by Hartwig <italic>et al.</italic><xref rid="dyy195-B16" ref-type="bibr"><sup>16</sup></xref> Details on the implementation of this approach with accompanying examples can be found in the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>, available at <italic>IJE</italic> online.</p>
    </sec>
    <sec>
      <title>Visualizing MR estimates</title>
      <p>One useful approach to presenting the results of MR analyses is to produce a scatterplot, with the x and y axes representing the instrument-exposure and instrument-outcome associations, respectively, for each variant. If one were to draw a hypothetical regression line leading from the origin to each variant, the slope of the line would represent a ratio estimate of the causal effect using the single variant as an instrument, that is dividing the instrument-outcome association by the instrument-exposure association (defined as <inline-formula id="IE27"><mml:math id="IM27"><mml:msub><mml:mrow><mml:mo>β</mml:mo></mml:mrow><mml:mrow><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> above). The precision of the instrument-outcome association estimate for each variant is illustrated using vertical error bars, whereas horizontal error bars pertaining to the instrument-exposure association may be omitted for clarity. As the IVW, MR-Egger, median and modal approaches essentially meta-analyse the set of ratio estimates, it is possible to include regression lines highlighting effect estimates of each approach for comparison. For such regression lines, positive and negative slopes are indicative of a positive or negative effect, respectively, whereas a slope of zero represents the absence of an observed association.</p>
    </sec>
  </sec>
  <sec>
    <title>Implementation</title>
    <p>The mrrobust package uses functions from moremata,<xref rid="dyy195-B17" ref-type="bibr"><sup>17</sup></xref> addplot<xref rid="dyy195-B18" ref-type="bibr"><sup>18</sup></xref> and the heterogi<xref rid="dyy195-B19" ref-type="bibr"><sup>19</sup></xref> command. For versions of Stata 13 and higher, it can be installed using the .net install command from [<ext-link ext-link-type="uri" xlink:href="https://raw.github.com/remlapmot/mrrobust/master/">https://raw.github.com/remlapmot/mrrobust/master/</ext-link>]. For older versions of Stata, a zip archive of the files is freely available for download at: [<ext-link ext-link-type="uri" xlink:href="https://github.com/remlapmot/mrrobust">https://github.com/remlapmot/mrrobust</ext-link>].</p>
    <p>The package facilitates two-sample summary MR analyses with key features including:
<list list-type="bullet"><list-item><p>IVW and MR-Egger regression approaches, including fixed effects MR-Egger regression, standard error correction and weighting options;</p></list-item><list-item><p>unweighted, weighted and penalized weighted median IV estimators, providing pleiotropy robust estimates in cases where fewer than 50% of the genetic instruments are valid;</p></list-item><list-item><p>modal estimation following Hartwig <italic>et al.</italic>,<xref rid="dyy195-B16" ref-type="bibr"><sup>16</sup></xref> including weighted and unweighted variations;</p></list-item><list-item><p>presentation of heterogeneity statistics, statistics such as <inline-formula id="IE28"><mml:math id="IM28"><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> for use in assessing attenuation bias,<xref rid="dyy195-B10" ref-type="bibr"><sup>10</sup></xref> and Simulation Extrapolation (SIMEX) correction following Bowden <italic>et al</italic>;<xref rid="dyy195-B10" ref-type="bibr"><sup>10</sup></xref></p></list-item><list-item><p>plotting tools to visualize IVW, MR-Egger and weighted median estimators, as well as density plotting with respect to implementing the modal estimator;</p></list-item><list-item><p>and illustrative examples and documentation using data from Do <italic>et al.</italic><xref rid="dyy195-B20" ref-type="bibr"><sup>20</sup></xref></p></list-item></list></p>
    <sec>
      <title>Applied examples: adiposity and height as predictors of serum glucose levels</title>
      <p>To illustrate key features of the mrrobust package, we perform two analyses investigating potential relationships between adiposity, height and serum glucose. Adiposity was selected owing to the vast body of evidence supporting a positive association with serum glucose levels,<xref rid="dyy195-B21" ref-type="bibr"><sup>21–24</sup></xref> whereas height was based upon limited evidence of association.<xref rid="dyy195-B25" ref-type="bibr"><sup>25–27</sup></xref> Glucose was selected as an outcome with respect to its hypothesized role in the development of type 2 diabetes.<xref rid="dyy195-B21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="dyy195-B27" ref-type="bibr"><sup>27</sup></xref> Datasets were obtained from the MR-Base web application and pruned for linkage disequilibrium before conducting the analyses.<xref rid="dyy195-B13" ref-type="bibr"><sup>13</sup></xref></p>
    </sec>
    <sec>
      <title>Applied example I: adiposity and serum glucose</title>
      <p>Though the relationship between adiposity and glucose has received much attention in the literature, such studies are predominantly observational and therefore may be subject to bias from confounding. This provides motivation for considering Mendelian randomization techniques which are able to control for such unobserved confounding. In the initial analysis, we select adiposity as an exposure measured using standardized body mass index (BMI), obtaining estimates of its associations with genotypes and their respective standard errors from Locke <italic>et al.</italic><xref rid="dyy195-B28" ref-type="bibr"><sup>28</sup></xref></p>
      <p>For the outcome, we consider log transformed measures of serum glucose <inline-formula id="IE29"><mml:math id="IM29"><mml:mtext>log</mml:mtext><mml:mo>(</mml:mo><mml:mi>m</mml:mi><mml:mi>M</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> using effect estimates and standard errors from Shin <italic>et al.</italic><xref rid="dyy195-B29" ref-type="bibr"><sup>29</sup></xref> The summary data used for this analysis are provided in the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>, available at <italic>IJE</italic> online. Adopting a GWAS significance <italic>P</italic>-value threshold of <inline-formula id="IE30"><mml:math id="IM30"><mml:mn>5</mml:mn><mml:mo>×</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:math></inline-formula> a total of 79 independent SNPs were identified in both samples. We confirmed the linkage equilibrium (LD) between the SNPs using a clumping algorithm, a clumping distance of 10000 kb and an LD <inline-formula id="IE31"><mml:math id="IM31"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math></inline-formula> of 0.001. This resulted in a total of 79 SNPs for use as instrumental variables, details of which are presented in the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>, available at <italic>IJE</italic> online.</p>
      <p>Using mrrobust, we conducted IVW, MR-Egger and weighted median regression approaches using the above summary data. The code for our analysis is in the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>, available at <italic>IJE</italic> online. For IVW and MR Egger approaches, the regression was weighted using the variance of the instrument-outcome association. The set of summary MR estimates are presented in <xref rid="dyy195-T1" ref-type="table">Table 1A</xref>.</p>
      <table-wrap id="dyy195-T1" orientation="portrait" position="float">
        <label>Table 1.</label>
        <caption>
          <p>Summary MR estimates for the effect of standardized BMI (A) and height (B) upon log transformed serum glucose</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1">Estimate</th>
              <th rowspan="1" colspan="1">SE</th>
              <th rowspan="1" colspan="1"><italic>P</italic>-value</th>
              <th rowspan="1" colspan="1">95% CI</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td colspan="5" rowspan="1">
                <bold>BMI (A)</bold>
              </td>
            </tr>
            <tr>
              <td colspan="5" rowspan="1"> IVW</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">  Effect</td>
              <td align="char" char="." rowspan="1" colspan="1">0.023</td>
              <td align="char" char="." rowspan="1" colspan="1">0.008</td>
              <td align="char" char="." rowspan="1" colspan="1">0.004</td>
              <td align="char" char="." rowspan="1" colspan="1">0.01, 0.04</td>
            </tr>
            <tr>
              <td colspan="5" rowspan="1"> MR Egger</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">  Intercept</td>
              <td align="char" char="." rowspan="1" colspan="1">0.000</td>
              <td align="char" char="." rowspan="1" colspan="1">0.001</td>
              <td align="char" char="." rowspan="1" colspan="1">0.948</td>
              <td align="char" char="." rowspan="1" colspan="1">−0.001, 0.001</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">  Effect</td>
              <td align="char" char="." rowspan="1" colspan="1">0.022</td>
              <td align="char" char="." rowspan="1" colspan="1">0.022</td>
              <td align="char" char="." rowspan="1" colspan="1">0.325</td>
              <td align="char" char="." rowspan="1" colspan="1">−0.02, 0.07</td>
            </tr>
            <tr>
              <td colspan="5" rowspan="1"> Weighted median</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">  Effect</td>
              <td align="char" char="." rowspan="1" colspan="1">0.034</td>
              <td align="char" char="." rowspan="1" colspan="1">0.012</td>
              <td align="char" char="." rowspan="1" colspan="1">0.005</td>
              <td align="char" char="." rowspan="1" colspan="1">0.01, 0.06</td>
            </tr>
            <tr>
              <td colspan="5" rowspan="1">
                <bold>Height (B)</bold>
              </td>
            </tr>
            <tr>
              <td colspan="5" rowspan="1"> IVW</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">  Effect</td>
              <td align="char" char="." rowspan="1" colspan="1">0.002</td>
              <td align="char" char="." rowspan="1" colspan="1">0.003</td>
              <td align="char" char="." rowspan="1" colspan="1">0.641</td>
              <td align="char" char="." rowspan="1" colspan="1">−0.005, 0.008</td>
            </tr>
            <tr>
              <td colspan="5" rowspan="1"> MR Egger</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">  Intercept</td>
              <td align="char" char="." rowspan="1" colspan="1">0.0001</td>
              <td align="char" char="." rowspan="1" colspan="1">0.0003</td>
              <td align="char" char="." rowspan="1" colspan="1">0.627</td>
              <td align="char" char="." rowspan="1" colspan="1">−0.0001, 0.0001</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">  Effect</td>
              <td align="char" char="." rowspan="1" colspan="1">0.003</td>
              <td align="char" char="." rowspan="1" colspan="1">0.009</td>
              <td align="char" char="." rowspan="1" colspan="1">0.777</td>
              <td align="char" char="." rowspan="1" colspan="1">−0.02, 0.02</td>
            </tr>
            <tr>
              <td colspan="5" rowspan="1"> Weighted median</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">  Effect</td>
              <td align="char" char="." rowspan="1" colspan="1">&lt;0.0001</td>
              <td align="char" char="." rowspan="1" colspan="1">0.005</td>
              <td align="char" char="." rowspan="1" colspan="1">&gt;0.99</td>
              <td align="char" char="." rowspan="1" colspan="1">−0.01, 0.01</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn1">
            <p>SE, standard error.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>We find strong evidence of a positive association between BMI and serum glucose, using both IVW and weighted median methods. Considering the MR Egger case, a substantial average directional pleiotropic effect was not detected, and the lack of significance with respect to the effect estimate can be attributed to a lack of statistical power. An<inline-formula id="IE32"><mml:math id="IM32"><mml:mi mathvariant="normal"> </mml:mi><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> value of 0.88 was reported, which can be interpreted as a relative bias in the MR-Egger estimate of 12% towards the null. The estimates are shown in <xref ref-type="fig" rid="dyy195-F1">Figure 1A</xref>, constructed using the mreggerplot command which generates a scatterplot of the instrument-exposure and instrument-outcome associations for each variant. This shows the set of estimates to be in agreement, with the plot being constructed as previously described.
</p>
      <fig id="dyy195-F1" orientation="portrait" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>mreggerplot output for applied examples using BMI (A) and height (B) as exposures.</p>
        </caption>
        <graphic xlink:href="dyy195f1"/>
      </fig>
    </sec>
    <sec>
      <title>Applied example II: height and serum glucose</title>
      <p>As a further example, we consider the effect of standardized height (metres) upon serum glucose, using summary data from Wood <italic>et al</italic>.<xref rid="dyy195-B30" ref-type="bibr"><sup>30</sup></xref> and outcome summary data on log transformed serum glucose from Shin <italic>et al.</italic><xref rid="dyy195-B29" ref-type="bibr"><sup>29</sup></xref> The summary data used for this analysis are provided in the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref>, available at <italic>IJE</italic> online. We assess the SNPS for LD using criteria from the previous example and identify 367 SNPs as suitable instruments for the analysis, details of which are presented in the <xref ref-type="supplementary-material" rid="sup1">Supplementary material</xref> as above. The set of summary MR estimates are presented in <xref rid="dyy195-T1" ref-type="table">Table 1B</xref>.</p>
      <p>From <xref rid="dyy195-T1" ref-type="table">Table 1B</xref>, we find no evidence against the null hypothesis of no association between height and serum glucose levels using IVW, weighted median and MR Egger regression. Considering the MR Egger case, there appeared to be no evidence of directional pleiotropy, with an <inline-formula id="IE33"><mml:math id="IM33"><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> value of 0.90 indicating a relative bias of 10% towards the null. As in the previous example, a plot of the MR estimates can be generated using the mreggerplot command as shown in <xref ref-type="fig" rid="dyy195-F1">Figure 1B</xref>. In this scenario, the estimates appear in agreement, indicating a lack of evidence for a substantial directional pleiotropic effect.</p>
    </sec>
  </sec>
  <sec sec-type="discussion">
    <title>Discussion</title>
    <p>The mrrobust package is a freely available Stata package, containing a number of summary MR estimation methods which can be used to estimate causal effects. In the applied example, the mrrobust package was able to provide a series of estimates, finding evidence of a positive association between BMI and serum glucose and no evidence of association between height and serum glucose. One possible conclusion that can be drawn from these results is that previously reported associations between height and glucose are driven by confounding factors.<xref rid="dyy195-B31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="dyy195-B32" ref-type="bibr"><sup>32</sup></xref> It is important, however, to consider the extent to which Mendelian randomization is appropriate for a given analysis and, by extension, situations in which mrrobust is suitable.</p>
    <p>In the first instance, Mendelian randomization studies only produce unbiased estimates when genetic instruments satisfy the assumptions of each estimator (e.g. IVW, MR-Egger or weighted median). In two-sample analyses, genetic instruments should be associated with the exposure of interest at genome-wide levels of significance (satisfying the first instrumental variable assumption), and pruned for LD to limit the overlap between SNPs. The IVW estimator also requires that genetic variants should not have directional pleiotropic effects. The MR Egger and median estimators are robust to directional pleiotropy if the effects of the exposure are constant. MR Egger regression requires the InSIDE assumption, whereas median methods assume that the number of valid instruments is greater than 50%. For MR-Egger estimation where the value of <inline-formula id="IE34"><mml:math id="IM34"><mml:msubsup><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>G</mml:mi><mml:mi>X</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math></inline-formula> is low, it is possible to use SIMEX to correct for regression attenuation towards the null. This is implemented using the mreggersimex command.</p>
    <p>In this paper, we have presented the mrrobust Stata package as an accessible toolkit for performing summary MR and instrumental variable analysis using many instruments. It contains a range of summary MR approaches, and should make examining causal relationships using Mendelian randomization more accessible for genetic epidemiologists.</p>
  </sec>
  <sec>
    <title>Funding</title>
    <p>The Medical Research Council (MRC) and the University of Bristol fund the MRC Integrative Epidemiology Unit (MC UU 12013/1, MC UU 12013/9, MC UU 00011/1). W.S. is funded by the Wellcome Trust (108902/B/15/Z).</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>dyy195_Supplementary_Material</label>
      <media xlink:href="dyy195_supplementary_material.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors would like to thank Michael Holmes, Caroline Dale, Amy Taylor, Rebecca Richmond, Judith Brand, Yanchun Bao and Kawthar Al-Dabhani for helpful comments on the programs.</p>
    <p><bold>Conflict of interest:</bold> None declared.</p>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="dyy195-B1">
      <label>1</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ebrahim</surname><given-names>S.</given-names></name></person-group><article-title>‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?</article-title><source>Int J Epidemiol</source><year>2003</year>;<volume>32</volume>:<fpage>1</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">12689998</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B2">
      <label>2</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Timpson</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Ebrahim</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group><article-title>Mendelian randomization: where are we now and where are we going?</article-title><source>Int J Epidemiol</source><year>2015</year>;<volume>44</volume>:<fpage>379</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">26085674</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B3">
      <label>3</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group><article-title>Mendelian randomization: new applications in the coming age of hypothesis-free causality</article-title>. <source>Annu Rev Genomics Hum Genet</source><year>2015</year>;<volume>16</volume>:<fpage>327</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">25939054</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B4">
      <label>4</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scholder</surname><given-names>SVK</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Lawlor</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Propper</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Windmeijer</surname><given-names>F.</given-names></name></person-group><article-title>Mendelian randomization: the use of genes in instrumental variable analyses</article-title>. <source>Health Econ</source><year>2011</year>;<volume>20</volume>:<fpage>893</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">21612002</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B5">
      <label>5</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Small</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG.</given-names></name></person-group><article-title>A review of instrumental variable estimators for Mendelian randomization</article-title>. <source>Stat Methods Med Res</source><year>2017</year>;<volume>26</volume>:2333–55.</mixed-citation>
    </ref>
    <ref id="dyy195-B6">
      <label>6</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davies</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>von Hinke Kessler Scholder</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Farbmacher</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Windmeijer</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G.</given-names></name></person-group><article-title>The many weak instruments problem and Mendelian randomization</article-title>. <source>Stat Med</source><year>2015</year>;<volume>34</volume>:<fpage>454</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">25382280</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B7">
      <label>7</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG.</given-names></name></person-group><article-title>Use of allele scores as instrumental variables for Mendelian randomization</article-title>. <source>Int J Epidemiol</source><year>2013</year>;<volume>42</volume>:<fpage>1134</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">24062299</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B8">
      <label>8</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowden</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>S.</given-names></name></person-group><article-title>Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression</article-title>. <source>Int J Epidemiol</source><year>2015</year>;<volume>44</volume>:<fpage>512</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">26050253</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B9">
      <label>9</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Butterworth</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG.</given-names></name></person-group><article-title>Mendelian randomization analysis with multiple genetic variants using summarized data</article-title>. <source>Genet Epidemiol</source><year>2013</year>;<volume>37</volume>:<fpage>658</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">24114802</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B10">
      <label>10</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowden</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Del Greco</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Minelli</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sheehan</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>JR.</given-names></name></person-group><article-title>Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic</article-title>. <source>Int J Epidemiol</source><year>2016</year>;<volume>45</volume>;<fpage>1961</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">27616674</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B11">
      <label>11</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowden</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Del Greco</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Minelli</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sheehan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>J.</given-names></name></person-group><article-title>A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization</article-title>. <source>Stat Med</source><year>2017</year>;<volume>36</volume><bold>:</bold><fpage>1783</fpage>–<lpage>802</lpage>.<pub-id pub-id-type="pmid">28114746</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B12">
      <label>12</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yavorska</surname><given-names>OO</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>S.</given-names></name></person-group><article-title>MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data</article-title>. <source>Int J Epidemiol</source><year>2017</year>;<volume>46</volume>:<fpage>1734</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="pmid">28398548</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B13">
      <label>13</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Hemani</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wade</surname><given-names>KH</given-names></name></person-group><etal>et al</etal> MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations. <italic>bioRxiv</italic><year>2016</year>, December 16. doi.org/10.1101/078972.</mixed-citation>
    </ref>
    <ref id="dyy195-B14">
      <label>14</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Baum</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schaffer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Stillman</surname><given-names>S.</given-names></name></person-group> IVREG2: Stata module for extended instrumental variables/2SLS and GMM estimation. Boston College Department of Economics, <year>2016</year>.</mixed-citation>
    </ref>
    <ref id="dyy195-B15">
      <label>15</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowden</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Haycock</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Burgess</surname><given-names>S.</given-names></name></person-group><article-title>Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator</article-title>. <source>Genet Epidemiol</source><year>2016</year>;<volume>40</volume>:<fpage>304</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">27061298</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B16">
      <label>16</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartwig</surname><given-names>FP</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bowden</surname><given-names>J.</given-names></name></person-group><article-title>Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption</article-title>. <source>Int J Epidemiol</source><year>2017</year>;<volume>46</volume>:<fpage>1985</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">29040600</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B17">
      <label>17</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Jann</surname><given-names>B.</given-names></name></person-group> MOREMATA: Stata module (Mata) to provide various functions. Statistical Software Components. Boston College Department of Economics, <year>2005</year>.</mixed-citation>
    </ref>
    <ref id="dyy195-B18">
      <label>18</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jann</surname><given-names>B.</given-names></name></person-group><article-title>A note on adding objects to an existing twoway graph</article-title>. <source>Stata J</source><year>2015</year>;<volume>15</volume>:<fpage>751</fpage>–<lpage>55</lpage>.</mixed-citation>
    </ref>
    <ref id="dyy195-B19">
      <label>19</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Orsini</surname><given-names>NHJ</given-names></name>, <name name-style="western"><surname>Bottai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Buchan</surname><given-names>I.</given-names></name></person-group> heterogi: Stata module to quantify heterogeneity in a meta-analysis. Statistical Software Components. Boston College Department of Economics, <year>2006</year>.</mixed-citation>
    </ref>
    <ref id="dyy195-B20">
      <label>20</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Do</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Willer</surname><given-names>CJ</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>EM</given-names></name></person-group><etal>et al</etal><article-title>Common variants associated with plasma triglycerides and risk for coronary artery disease</article-title>. <source>Nat Genet</source><year>2013</year>;<volume>45</volume>:<fpage>1345</fpage>.<pub-id pub-id-type="pmid">24097064</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B21">
      <label>21</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boden</surname><given-names>G.</given-names></name></person-group><article-title>Role of fatty acids in the pathogenesis of insulin resistance and NIDDM</article-title>. <source>Diabetes</source><year>1997</year>;<volume>46</volume>:<fpage>3</fpage>–<lpage>10</lpage>.<pub-id pub-id-type="pmid">8971073</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B22">
      <label>22</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Reaven</surname><given-names>G.</given-names></name></person-group><article-title>Obesity and insulin resistance: an ongoing saga</article-title>. <source>Diabetes</source><year>2010</year>;<volume>59</volume>:<fpage>2105</fpage>–<lpage>06</lpage>.<pub-id pub-id-type="pmid">20805385</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B23">
      <label>23</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O’Gorman</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Karlsson</surname><given-names>HKR</given-names></name>, <name name-style="western"><surname>McQuaid</surname><given-names>S</given-names></name></person-group><etal>et al</etal><article-title>Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes</article-title>. <source>Diabetologia</source><year>2006</year>;<volume>49</volume>:<fpage>2983</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">17019595</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B24">
      <label>24</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hjerkind</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Stenehjem</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Nilsen</surname><given-names>TI.</given-names></name></person-group><article-title>Adiposity, physical activity and risk of diabetes mellitus: prospective data from the population-based HUNT study, Norway</article-title>. <source>BMJ Open</source><year>2017</year>;<volume>7</volume>:<fpage>e013142</fpage>.</mixed-citation>
    </ref>
    <ref id="dyy195-B25">
      <label>25</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogonowski</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Miazgowski</surname><given-names>T.</given-names></name></person-group><article-title>Are short women at risk for gestational diabetes mellitus?</article-title><source>Eur J Endocrinol</source><year>2010</year>;<volume>162</volume>:<fpage>491</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">19952123</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B26">
      <label>26</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Byrne</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Clark</surname><given-names>PM</given-names></name></person-group><etal>et al</etal><article-title>Height and glucose tolerance in adult subjects</article-title>. <source>Diabetologia</source><year>1991</year>;<volume>34</volume>:<fpage>531</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="pmid">1916060</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B27">
      <label>27</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asao</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kao</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Baptiste-Roberts</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bandeen-Roche</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Erlinger</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Brancati</surname><given-names>FL.</given-names></name></person-group><article-title>Short stature and the risk of adiposity, insulin resistance, and type 2 diabetes in middle age: the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994</article-title>. <source>Diabetes Care</source><year>2006</year>;<volume>29</volume>:<fpage>1632</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">16801590</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B28">
      <label>28</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locke</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Kahali</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Berndt</surname><given-names>SI</given-names></name></person-group><etal>et al</etal><article-title>Genetic studies of body mass index yield new insights for obesity biology</article-title>. <source>Nature</source><year>2015</year>;<volume>518</volume>:<fpage>684</fpage><lpage>690</lpage>.</mixed-citation>
    </ref>
    <ref id="dyy195-B29">
      <label>29</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shin</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Fauman</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>AK</given-names></name></person-group><etal>et al</etal><article-title>An atlas of genetic influences on human blood metabolites</article-title>. <source>Nat Genet</source><year>2014</year>;<volume>46</volume>:<fpage>543</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">24816252</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B30">
      <label>30</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wood</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Esko</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>J</given-names></name></person-group><etal>et al</etal><article-title>Defining the role of common variation in the genomic and biological architecture of adult human height</article-title>. <source>Nat Genet</source><year>2014</year>;<volume>46</volume>:<fpage>1173</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">25282103</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B31">
      <label>31</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olatunbosun</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Bella</surname><given-names>AF.</given-names></name></person-group><article-title>Relationship between height, glucose intolerance, and hypertension in an urban African black adult population: a case for the “thrifty phenotype” hypothesis?</article-title><source>J Natl Med Assoc</source><year>2000</year>;<volume>92</volume>:<fpage>265</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">10918760</pub-id></mixed-citation>
    </ref>
    <ref id="dyy195-B32">
      <label>32</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rehunen</surname><given-names>SKJ</given-names></name>, <name name-style="western"><surname>Kautiainen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Eriksson</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Korhonen</surname><given-names>PE.</given-names></name></person-group><article-title>Adult height and glucose tolerance: a re-appraisal of the importance of body mass index</article-title>. <source>Diabet Med</source><year>2017</year>;<volume>34</volume>:<fpage>1129</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">28508445</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
